An investment of $90 million in the Medtech Convergence Fund (MCF), a healthcare venture-capital fund managed by SV Health Investors, London/United Kingdom, has been announced by the fiber-product converting company Teijin Frontier Co., Ltd., Tokyo/Japan.
The MCF is a venture capital fund aimed at entrepreneurs, healthcare professionals and inventors building medical technology companies. Through investment and collaboration with this new partner, Teijin aims to acquire new technologies and develop new businesses in the healthcare field, as well as to develop disruptive, cost-saving healthcare solutions.
This is following Teijin’s medium-term management plan for 2020-2022 to invest in community-based comprehensive healthcare solutions. MCF will focus on regulated medical devices in less-intensive care settings. This includes devices for the use in the private homes. These are especially important in societies with an aging rapidly population, like Japan.